Structural Heart Devices Global Market

–Forecast to 2024

Structural Heart Devices Global Market estimated to be worth $15,671.0 million

by 2024

IQ4I Research & Consultancy published a new report on “Structural Heart Devices
Global Market – Forecast To 2024” This report analyzes and studies the overall market,
major Drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific
and Rest of the World.

IQ4I’s Report Contains 88 market data tables and 75 figures spread through 337 pages
and an exhaustive TOC on “Structural Heart Devices Global Market”, [Structural heart
Products {Repair devices (Surgical Heart Repair and Transcatheter heart repair devices
(Valvuloplasty, Occluders, Transcatheter Mitral Valve Repair and Others), Replacement
devices (Surgical Valve Replacement (Mechanical valves and Tissue valves) and
Transcatheter Valve Replacement (TAVR, TMVR, TPVR)}, Region (North America, Europe,
Asia-Pacific and Rest of the World)]

Structural heart (SH) devices are used for the treatment of congenital heart diseases and
other diseases of heart that develop due to aging and reduce the effectiveness of functioning
of the heart. The major structural heart diseases include heart valve diseases (valve stenosis
and regurgitation) which are treated either by repair or replacement of the valve and septal
defects or heart holes (ASD, VSD, PDA, PFO, PVL), left atrial appendage are treated by
implanting occluders. According to IQ4I Analysis, Structural heart device market is expected
to grow at a double digit CAGR to reach $15,671.0 million by 2024.

Increase in the prevalence of heart valve disease due to rise in aging population,
technological advancement and demand for minimally invasive surgery are driving the
market growth. A vast number of pipeline products, growing healthcare budgetary allocation
and increasing funding for structural heart devices research are some of the growth
opportunities available in the market. However, lack of skilled and trained professionals and
high cost associated with the device and procedure are some of the restraints of the market.
Stringent regulatory requirements with high cost of device development and lack of patient
awareness and primary healthcare infrastructure in developing countries are some of the
threats of the market.

The structural heart devices global market is segmented into repair and replacement devices
based on the products. The replacement devices segment held the largest market revenue
in 2017 and expected to grow at a double digit CAGR from 2017 to 2024 due to
technological advancement in transcatheter based technology particularly in case of mitral
valve regurgitation (TMVR).

IQ4I Research & Consultancy Pvt. Ltd. Page 1

Structural Heart Devices Global Market

–Forecast to 2024

In structural heart repair devices segment, transcatheter repair device held the largest share
and is projected to grow at a strong double digit CAGR from 2017 to 2024. Among
transcatheter repair devices, Transcatheter mitral valve repair device held the largest share
and is projected to grow at a strong double digit CAGR from 2017 to 2024. Structural heart
Replacement segment is dominated by Transcatheter valve replacement and expected to
grow at a strong double digit CAGR from 2017 to 2024. Among transcatheter replacement
devices TMVR is expected to grow at a strong double digit CAGR as there is huge demand
for TMVR devices and numerous companies are developing transcatheter mitral valve
replacement devices. For instance, Abbott’s Tendyne Transcatheter Mitral Valve
Replacement has treated 100 patients in a global study, the first and only mitral replacement
valve that can be easily positioned and fully retrievable allowing more precise implantation,
for better patient outcomes. Some other companies which are developing TMVR devices are
Micro Interventional Devices - Permavalve - Mitral Valve Replacement, MitrAssist Ltd -
MitrAssist valve, NaviGate Cardiac Structures Inc - Navi mitral valved stent, strait access
technologies pty ltd - Synthetic heart valve.

Advanced technologies like cardiac or ventricular remodeling, chordal mitral valve

replacement, and transcatheter tricuspid valve replacement will drive the Structural heart
device market. Some of the Ventricular remodeling products include Parachute implant a
ventricular partitioning device from Cardiokinetix and Revivent TC TransCatheter ventricular
enhancement system from BioVenrix, both are CE approved and transcatheter tricuspid
valve replacement device from NaviGate Cardiac Structures Inc, which offers Gate Tricuspid
vavled stent which is Canadian approved. Some of the advanced technologies which are in
development phase are Novostia SA (Switzerland) - LTV a prosthetic heart valve resistant to
thrombosis, structural failure and not requiring anticoagulation therapy and Valcare Medical,
Inc. (Israel) - Amend mitral valve repair, a minimally-invasive annuloplasty anchoring system
that attaches to the annulus in four different zones with short procedure time. These
upcoming products will realize the unmet needs.

The Structural heart device market is consolidated with top five players occupying major
share of the market. The top players include Edward Lifesciences, Medtronic PLC, Abbott
Laboratories, Boston scientific and LivaNova. These companies are maintaining strong
position in the market by have a strong distribution network, by enhancing patents portfolio
and acquisition strategy. For instance, Abbott Laboratories acquired St.Jude medical in
January 2017, through this acquisition Abbott increased its product portfolio in structural
heart devices with range of products like occluders, valves and annuloplasty rings. Edward

IQ4I Research & Consultancy Pvt. Ltd. Page 2

Structural Heart Devices Global Market

–Forecast to 2024

lifesciences acquired Harpoon medical in December 2017 and gained access to HARPOON
system, an echo guided degenerative mitral regurgitation repair technology with fast
recovery and low morbidity.

The Structural heart devices global market based on geography is divided into North
America, Europe, Asia-Pacific and Rest of the world. North America region commanded the
largest share in 2017 and is expected to grow at a strong CAGR from 2017 to 2024. A high
prevalence of cardiovascular disease such as heart failure, cardiogenic shock, dilated
cardiomyopathy, ventricular insufficiency, Valvular heart disease, congenital heart diseases
and growth in aging population and favorable reimbursement coverage led the market
growth in this region. However, Asia-Pacific is expected to grow at a strong double digit
CAGR from 2017 to 2024 owing to the rapidly increasing aging population with high
prevalence of cardiovascular diseases, improving healthcare infrastructure and rise in
healthcare spending in the emerging countries, such as India and China.

Major players in Structural heart device market include Abbott laboratories (U.S.), Medtronic
(Ireland), Boston Scientific (U.S.), Edward Lifesciences (U.S.), LivaNova (U.K.), Lepu
Medicals (China), JenaValve Technologies GmbH (Germany), Braile biomedia (Brazil),
Cryolife (U.S.), Labcore Laboratories ltd (Brazil).

Some of the key players operating in Structural heart device global market include
BioVentrix, Inc (U.S.), Balton Sp. z o.o (Poland), Cardiac dimensions, Inc (U.S.),
Cardiosolutions, Inc (U.S.), Colibri Heart Valve, LLC (U.S.), Effluent medicals (France),
Heart Leaflet Technologies (U.S.), Leman cardiovascular (Switzerland), Medtentia
International Ltd Oy (Finland), NaviGate Cardiac Structures Inc (U.S.), Neochord (U.S.),
Occlutech (Germany), Strait access technologies Pvt ltd (South Africa), TTK Chitra Valve
(India), Valcare medical (Israel).

IQ4I Research & Consultancy Pvt. Ltd. Page 3

Structural Heart Devices Global Market

–Forecast to 2024

Reasons for buying this report:

 Structural heart devices global market is expected to reach $15,671.0 million by 2024
at a CAGR of 14.8%.
 Identification and analysis of the structural heart devices market by identifying
various segments by product, product type and geography.
 Revenue forecast of structural heart devices market and strategic analysis of each
sub-segment with respect to segmental growth trends.
 Identification of major market trends, Porter's model, and factors driving and
restraining structural heart devices market growth.
 Market penetration analysis of structural heart devices and analysis of structural
heart devices global market by number of units and their average selling prices.
 Revenue forecast of the structural heart devices market with respect to North
America (U.S. and Others), Europe (Germany, Italy, France and Others), Asia-Pacific
(Japan, China, Korea and Others) and Rest of the World (Brazil, Rest of Latin
America and Middle-East & Others) regions.
 Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
 Identification of key technology developments and innovations driving the market.
 Analysis of the market share, patent and supply chain of the structural heart devices
market by major players.
 Individual market share of Annuloplasty repair devices, occluders, surgical
mechanical valve replacement devices, surgical tissue valve replacement devices
and Transcatheter aortic valve replacement devices.
 Profiles of major players in structural heart devices market and analysis of their
product offerings, financial revenue, business strategies, SWOTs and market shares.

IQ4I Research & Consultancy Pvt. Ltd. Page 4

Structural Heart Devices Global Market

–Forecast to 2024

FIGURE 1

STRUCTURAL HEART DEVICES GLOBAL MARKET SEGMENTATION

Structural Heart Devices Global Market

Products Region

Repair Replacement
NA EU APAC RoW
Devices Devices

Surgical Heart TC Heart Surgical TC Valve

U.S. Germany Japan Brazil
Repair Repair Replacement Replacement

Mechanical Rest of
Valvuloplasty TAVR Others Italy China
Valves LATAM

Middle East
Occluders Tissue Valves TMVR France Korea
and Others

TC Mitral
TPVR Others Others
Valve Repair

Others

Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American College
of Cardiology Foundation (ACC), American Heart Association (AHA), European Society of Cardiology (ESC),
World Heart Federation, Cardiovascular Research Foundation (CRF), Society of Thoracic Surgeons (STS), The
Heart Valve Society (HVS), Industrial Experts and IQ4I Analysis.

IQ4I Research & Consultancy Pvt. Ltd. Page 5